The real-life efficacy of early antiviral therapies in cancer patients with COVID-19 islargely uncharacterized. From these unresolved issues, it is therefore necessary to fillthese knowledge gaps by assessing the efficacy and safety of these therapies incombination with anti-cancer therapies.
Not Provided
Inclusion Criteria:
1. Patients ≥ 18 years diagnosed with and/or treated for solid tumors at the department
of Oncologia of the Fondazione IRCCS Policlinico San Matteo
2. Prospective patients (or their or legal guardians) who have the ability to
understand and be willing to sign a written informed consent document
3. Retrospective patients who have signed the institutional document allowing the use
of their data for research on their disease
Exclusion Criteria:
- Patients who are unable to understand informed consent document
Fondazione IRCCS Policlinico San Matteo, SC Oncologia
Pavia 3171366, Pavia, Italy
Not Provided